Bone-forming cells: Additional Phase IIa data

Additional data from 7 patients ages 40-85 who did not respond to anti-osteoporotic therapy in an investigator-led, open-label,

Read the full 181 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE